Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825655 · ClinicalTrials.gov registry record · Phase 4
Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT01825655: Clinical Trial Phase 4 study, sponsored by Virginia Commonwealth University.
NCT01825655 is a Phase 4 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01825655, a Phase 4 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is determine if long acting antihistamine like cetirizine can help with itching induced by opioid pain medications.
Primary Outcome
Itch score will be used to analyze our primary outcome. The subjects will have an itch score at baseline and compared to itch score at 3hrs post intervention. Itch score is measured on a scale of 1 to 4, with lower scores indicating less itchiness.
Interventions
- DRUG Cetirizine
- DRUG Placebo or sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
Why NCT01825655 stopped before completion
NCT01825655 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Cetirizine is the first listed.
NCT01825655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01825655 about?
NCT01825655 is a clinical study titled "Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching". The purpose of this study is determine if long acting antihistamine like cetirizine can help with itching induced by opioid pain medications.
What is the current status of trial NCT01825655?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2014-09. Estimated completion is 2017-11.
What interventions are being tested in trial NCT01825655?
The interventions under investigation include: Cetirizine (DRUG), Placebo or sugar pill (DRUG).
Who is sponsoring clinical trial NCT01825655?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01825655's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia